Through our vast network we help our corporate clients with their product strategy, in- and out-licensing efforts, including asset valuation (NPV, rNPV), M&A scouting, complex due dilligence and dealmaking from the first contact until the successful transaction.
We provide input on regulatory matters as well as support in pricing and reimbursement decisions and communication with decision-making authorities
We guide products from the basic science all the way to their successful commercialization or a spin-off.